| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-19 ERVK-24 ERVK-8 CTSD | 9.87e-11 | 37 | 204 | 9 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-19 ERVK-24 ERVK-8 CTSD | 1.28e-10 | 38 | 204 | 9 | GO:0070001 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 3.30e-06 | 11 | 204 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 9.77e-06 | 14 | 204 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.89e-05 | 18 | 204 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 5.52e-05 | 21 | 204 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 8.04e-05 | 70 | 204 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ERVK-6 ERVK-7 ERVK-10 PFKFB4 PTPRA PTPRF PTPRK NOTUM PTRHD1 PTPRQ EXOG VARS1 DUSP3 PON1 PTPN21 FANCM FICD PTPA ERVK-8 RPE65 CNOT1 | 8.45e-05 | 807 | 204 | 21 | GO:0016788 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP8A2 EFTUD2 GUF1 ASCC3 KIF25 KIF13B RAP2A DRG2 DNAH10 DYNC2H1 ATL3 ABCC11 FANCM ARF1 ARF3 ARF4 ARF5 ABCB11 KIF13A ATP2B1 | 1.40e-04 | 775 | 204 | 20 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP8A2 MOCS3 ASCC3 KIF25 KIF13B EP400 DNAH10 DYNC2H1 ABCC11 MSH3 FANCM DNAH1 ABCB11 MYO15A KIF13A ATP2B1 TOP2A | 1.99e-04 | 614 | 204 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.12e-04 | 118 | 204 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | GTP binding | INSR EFTUD2 GUF1 FKBP4 RAP2A DRG2 ATL3 UPRT ARF1 ARF3 ARF4 ARF5 TUBAL3 | 2.34e-04 | 397 | 204 | 13 | GO:0005525 |
| GeneOntologyMolecularFunction | phospholipase D activator activity | 3.10e-04 | 3 | 204 | 2 | GO:1990583 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 ERVK-7 ERVK-10 EXOG ASCC3 EP400 MSH3 FANCM ERVK-8 TOP2A | 3.78e-04 | 262 | 204 | 10 | GO:0140097 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP8A2 EFTUD2 GUF1 ASCC3 KIF25 KIF13B RAP2A DRG2 DNAH10 DYNC2H1 ATL3 ABCC11 FANCM ARF1 ARF3 ARF4 ARF5 ABCB11 KIF13A ATP2B1 | 3.94e-04 | 839 | 204 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP8A2 EFTUD2 GUF1 ASCC3 KIF25 KIF13B RAP2A DRG2 DNAH10 DYNC2H1 ATL3 ABCC11 FANCM ARF1 ARF3 ARF4 ARF5 ABCB11 KIF13A ATP2B1 | 4.00e-04 | 840 | 204 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP8A2 EFTUD2 GUF1 ASCC3 KIF25 KIF13B RAP2A DRG2 DNAH10 DYNC2H1 ATL3 ABCC11 FANCM ARF1 ARF3 ARF4 ARF5 ABCB11 KIF13A ATP2B1 | 4.00e-04 | 840 | 204 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CDH26 SCYL1 ITGA1 ITGAD ESYT2 PTPRF KDR PLXNB3 COL16A1 DSP BAG3 CAPZA1 TMPO EIF2A TNR TNXB | 4.56e-04 | 599 | 204 | 16 | GO:0050839 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 5.36e-04 | 37 | 204 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.36e-04 | 37 | 204 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 5.95e-04 | 38 | 204 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | INSR EFTUD2 GUF1 FKBP4 RAP2A DRG2 ATL3 UPRT ARF1 ARF3 ARF4 ARF5 TUBAL3 | 6.08e-04 | 439 | 204 | 13 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | INSR EFTUD2 GUF1 FKBP4 RAP2A DRG2 ATL3 UPRT ARF1 ARF3 ARF4 ARF5 TUBAL3 | 6.08e-04 | 439 | 204 | 13 | GO:0019001 |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 6.15e-04 | 4 | 204 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 6.15e-04 | 4 | 204 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 6.15e-04 | 4 | 204 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 6.15e-04 | 4 | 204 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 6.43e-04 | 17 | 204 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 6.43e-04 | 17 | 204 | 3 | GO:0019198 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 6.64e-04 | 103 | 204 | 6 | GO:0004725 | |
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 CDH26 ADGRV1 LRP1B ESYT2 FAT2 HMCN2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGA10 FAT3 PON1 APCS PCDHA5 CELSR1 | 7.04e-04 | 749 | 204 | 18 | GO:0005509 |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 SPTB INSR ERVK-7 ERVK-21 ERVK-9 ERVK-10 NUP205 HMCN2 ERVK-19 ERVK-24 COL6A3 SORBS2 COL16A1 DSP MRPS15 ERVK-8 ERVK-5 TNXB TUBAL3 | 8.35e-04 | 891 | 204 | 20 | GO:0005198 |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 9.73e-04 | 152 | 204 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | protein-lysine 6-oxidase activity | 1.02e-03 | 5 | 204 | 2 | GO:0004720 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.23e-03 | 46 | 204 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.29e-03 | 79 | 204 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-19 ERVK-24 CELA3A THOP1 ERVK-8 SENP6 CTSD | 1.62e-03 | 430 | 204 | 12 | GO:0004175 |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | PFKFB4 PTPRA PTPRF PTPRK NOTUM PTPRQ DUSP3 PON1 PTPN21 FICD PTPA | 2.14e-03 | 386 | 204 | 11 | GO:0042578 |
| GeneOntologyMolecularFunction | integrin binding | 2.18e-03 | 175 | 204 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 ERVK-7 ERVK-10 PTRHD1 EXOG ASCC3 VARS1 EP400 POLR2H CARS1 MSH3 FANCM ERVK-8 CNOT1 TOP2A | 2.67e-03 | 645 | 204 | 15 | GO:0140640 |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.77e-03 | 136 | 204 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.85e-03 | 28 | 204 | 3 | GO:0051959 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 CDH26 FAT2 HMCN2 PTPRF PCDH11X PCDH15 PLXNB3 FAT4 DSC3 PCDHGB7 PCDHGA10 FAT3 PCDHA5 CELSR1 | 5.09e-10 | 187 | 202 | 15 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 CDH26 FAT2 HMCN2 PTPRF PCDH11X PCDH15 PLXNB3 FAT4 DSC3 PCDHGB7 PCDHGA10 FAT3 PCDHA5 CELSR1 IL1RN | 8.49e-08 | 313 | 202 | 16 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | MAGI1 DCHS2 CDH26 PIEZO1 ETS1 ITGA1 ADGRV1 ITGAD FAT2 HMCN2 PTPRF PCDH11X PCDH15 LOXL3 ALOX12 PLXNB3 FAT4 DSC3 PCDHGB7 DSP PCDHGA10 DTX1 FAT3 DUSP3 PCDHA5 LEP CELSR1 IL1RN TNR TNXB | 2.27e-07 | 1077 | 202 | 30 | GO:0098609 |
| GeneOntologyBiologicalProcess | DNA integration | 5.96e-06 | 13 | 202 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | neuron development | ARHGAP32 ATP8A2 SCYL1 SPART ITGA1 ADGRV1 C12orf57 HMCN2 PTPRF PTPRK PTPRQ PCDH15 KDR FKBP4 PLXNB3 MRTFA KIF13B FAT4 RAP2A RPGRIP1L FAT3 ZNF212 SPG11 VPS54 OGDH SPAG6 LEP ARF1 ARF4 IGF2BP1 TNR TNXB | 1.52e-05 | 1463 | 202 | 32 | GO:0048666 |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | SCYL1 AP1G1 SNX12 COG2 ATL3 VPS54 ARF1 ARF3 ARF4 ARF5 SCAP KIF13A EXOC4 | 3.16e-05 | 339 | 202 | 13 | GO:0048193 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | ITGA1 ITGAD FAT2 PTPRA PTPRK SGCE KDR FNDC3B COL16A1 WASHC2C DUSP3 SORBS1 SPAG6 TNXB | 5.56e-05 | 410 | 202 | 14 | GO:0031589 |
| GeneOntologyBiologicalProcess | establishment of planar polarity | 6.83e-05 | 44 | 202 | 5 | GO:0001736 | |
| GeneOntologyBiologicalProcess | establishment of tissue polarity | 7.62e-05 | 45 | 202 | 5 | GO:0007164 | |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 8.08e-05 | 73 | 202 | 6 | GO:0001738 | |
| GeneOntologyBiologicalProcess | Golgi to transport vesicle transport | 9.54e-05 | 2 | 202 | 2 | GO:0055108 | |
| GeneOntologyBiologicalProcess | neuron projection development | ARHGAP32 ATP8A2 SPART ITGA1 ADGRV1 C12orf57 HMCN2 PTPRF PTPRK PCDH15 KDR FKBP4 PLXNB3 MRTFA KIF13B FAT4 RAP2A FAT3 ZNF212 SPG11 VPS54 SPAG6 ARF1 ARF4 IGF2BP1 TNR TNXB | 1.47e-04 | 1285 | 202 | 27 | GO:0031175 |
| Domain | Cadherin_CS | DCHS2 CDH26 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGA10 FAT3 PCDHA5 CELSR1 | 1.55e-09 | 109 | 195 | 12 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 CDH26 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGA10 FAT3 PCDHA5 CELSR1 | 2.35e-09 | 113 | 195 | 12 | PS00232 |
| Domain | Cadherin | DCHS2 CDH26 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGA10 FAT3 PCDHA5 CELSR1 | 2.35e-09 | 113 | 195 | 12 | PF00028 |
| Domain | CADHERIN_2 | DCHS2 CDH26 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGA10 FAT3 PCDHA5 CELSR1 | 2.61e-09 | 114 | 195 | 12 | PS50268 |
| Domain | - | DCHS2 CDH26 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGA10 FAT3 PCDHA5 CELSR1 | 2.61e-09 | 114 | 195 | 12 | 2.60.40.60 |
| Domain | CA | DCHS2 CDH26 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGA10 FAT3 PCDHA5 CELSR1 | 2.88e-09 | 115 | 195 | 12 | SM00112 |
| Domain | Cadherin-like | DCHS2 CDH26 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGA10 FAT3 PCDHA5 CELSR1 | 3.19e-09 | 116 | 195 | 12 | IPR015919 |
| Domain | Cadherin | DCHS2 CDH26 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGA10 FAT3 PCDHA5 CELSR1 | 3.88e-09 | 118 | 195 | 12 | IPR002126 |
| Domain | P-loop_NTPase | MAGI1 PFKFB4 EFTUD2 GUF1 ASCC3 KIF25 KIF13B RAP2A DRG2 EP400 DNAH10 DYNC2H1 ATL3 ABCC11 MSH3 FANCM ARF1 ARF3 ARF4 ARF5 DNAH1 ABCB11 MYO15A KIF13A | 8.97e-06 | 848 | 195 | 24 | IPR027417 |
| Domain | - | 6.18e-05 | 95 | 195 | 7 | 2.60.120.200 | |
| Domain | CKAP2_C | 1.08e-04 | 2 | 195 | 2 | IPR029197 | |
| Domain | NID | 1.08e-04 | 2 | 195 | 2 | PF07292 | |
| Domain | CKAP2_fam | 1.08e-04 | 2 | 195 | 2 | IPR026165 | |
| Domain | CSTF2_hinge | 1.08e-04 | 2 | 195 | 2 | PF14327 | |
| Domain | CSTF_C | 1.08e-04 | 2 | 195 | 2 | PF14304 | |
| Domain | CKAP2_C | 1.08e-04 | 2 | 195 | 2 | PF15297 | |
| Domain | CSTF2_hinge | 1.08e-04 | 2 | 195 | 2 | IPR025742 | |
| Domain | IFP_35_N | 1.08e-04 | 2 | 195 | 2 | PF07334 | |
| Domain | Nmi/IFP35_N | 1.08e-04 | 2 | 195 | 2 | IPR009938 | |
| Domain | Nmi/IFP35_dom | 1.08e-04 | 2 | 195 | 2 | IPR009909 | |
| Domain | FAM21 | 1.08e-04 | 2 | 195 | 2 | IPR027308 | |
| Domain | CSTF_C | 1.08e-04 | 2 | 195 | 2 | IPR026896 | |
| Domain | - | PFKFB4 EFTUD2 GUF1 ASCC3 RAP2A DRG2 EP400 DNAH10 DYNC2H1 ATL3 ABCC11 MSH3 FANCM ARF1 ARF3 ARF4 ARF5 DNAH1 ABCB11 MYO15A | 1.10e-04 | 746 | 195 | 20 | 3.40.50.300 |
| Domain | VWFA | 2.17e-04 | 82 | 195 | 6 | PS50234 | |
| Domain | ARF | 2.23e-04 | 29 | 195 | 4 | PS51417 | |
| Domain | Small_GTPase_ARF | 2.23e-04 | 29 | 195 | 4 | IPR024156 | |
| Domain | VWA | 2.48e-04 | 84 | 195 | 6 | SM00327 | |
| Domain | Arf | 2.91e-04 | 31 | 195 | 4 | PF00025 | |
| Domain | SOHO | 3.23e-04 | 3 | 195 | 2 | PS50831 | |
| Domain | F_ACTIN_CAPPING_A_1 | 3.23e-04 | 3 | 195 | 2 | PS00748 | |
| Domain | F_ACTIN_CAPPING_A_2 | 3.23e-04 | 3 | 195 | 2 | PS00749 | |
| Domain | F-actin_cap_A | 3.23e-04 | 3 | 195 | 2 | PF01267 | |
| Domain | CapZ_alpha | 3.23e-04 | 3 | 195 | 2 | IPR002189 | |
| Domain | F-actin_cap_asu_CS | 3.23e-04 | 3 | 195 | 2 | IPR017865 | |
| Domain | CAP-ZIP_m | 3.23e-04 | 3 | 195 | 2 | PF15255 | |
| Domain | Sorb | 3.23e-04 | 3 | 195 | 2 | SM00459 | |
| Domain | FAM21/CAPZIP | 3.23e-04 | 3 | 195 | 2 | IPR029341 | |
| Domain | Sorb | 3.23e-04 | 3 | 195 | 2 | PF02208 | |
| Domain | SoHo_dom | 3.23e-04 | 3 | 195 | 2 | IPR003127 | |
| Domain | Laminin_G | 3.45e-04 | 58 | 195 | 5 | IPR001791 | |
| Domain | Small_GTPase_ARF/SAR | 3.72e-04 | 33 | 195 | 4 | IPR006689 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.75e-04 | 14 | 195 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.75e-04 | 14 | 195 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.75e-04 | 14 | 195 | 3 | IPR013602 | |
| Domain | DHC_N2 | 3.75e-04 | 14 | 195 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.75e-04 | 14 | 195 | 3 | IPR011704 | |
| Domain | MT | 3.75e-04 | 14 | 195 | 3 | PF12777 | |
| Domain | AAA_8 | 3.75e-04 | 14 | 195 | 3 | PF12780 | |
| Domain | AAA_5 | 3.75e-04 | 14 | 195 | 3 | PF07728 | |
| Domain | Small_GTP-bd_dom | 3.76e-04 | 167 | 195 | 8 | IPR005225 | |
| Domain | DHC_fam | 4.65e-04 | 15 | 195 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 4.65e-04 | 15 | 195 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.65e-04 | 15 | 195 | 3 | IPR004273 | |
| Domain | PTPc | 5.23e-04 | 36 | 195 | 4 | SM00194 | |
| Domain | VWF_A | 6.01e-04 | 99 | 195 | 6 | IPR002035 | |
| Domain | Kinesin-like_KIF1-typ | 6.42e-04 | 4 | 195 | 2 | IPR022140 | |
| Domain | KIF1B | 6.42e-04 | 4 | 195 | 2 | PF12423 | |
| Domain | LAM_G_DOMAIN | 6.44e-04 | 38 | 195 | 4 | PS50025 | |
| Domain | TYR_PHOSPHATASE_PTP | 7.12e-04 | 39 | 195 | 4 | PS50055 | |
| Domain | Laminin_G_2 | 7.85e-04 | 40 | 195 | 4 | PF02210 | |
| Domain | EGF_3 | 8.35e-04 | 235 | 195 | 9 | PS50026 | |
| Domain | PTPase_domain | 8.63e-04 | 41 | 195 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 8.63e-04 | 41 | 195 | 4 | PF00102 | |
| Domain | Ig_I-set | 8.81e-04 | 190 | 195 | 8 | IPR013098 | |
| Domain | I-set | 8.81e-04 | 190 | 195 | 8 | PF07679 | |
| Domain | Tyr_Pase_AS | 9.96e-04 | 73 | 195 | 5 | IPR016130 | |
| Domain | Lysyl_oxidase | 1.06e-03 | 5 | 195 | 2 | IPR001695 | |
| Domain | LYSYL_OXIDASE | 1.06e-03 | 5 | 195 | 2 | PS00926 | |
| Domain | Lysyl_oxidase_CS | 1.06e-03 | 5 | 195 | 2 | IPR019828 | |
| Domain | Lysyl_oxidase | 1.06e-03 | 5 | 195 | 2 | PF01186 | |
| Domain | LamG | 1.13e-03 | 44 | 195 | 4 | SM00282 | |
| Domain | EGF-like_dom | 1.25e-03 | 249 | 195 | 9 | IPR000742 | |
| Domain | EGF_1 | 1.48e-03 | 255 | 195 | 9 | PS00022 | |
| Domain | Kinesin_assoc | 1.58e-03 | 6 | 195 | 2 | PF16183 | |
| Domain | EFG_C | 1.58e-03 | 6 | 195 | 2 | PF00679 | |
| Domain | Kinesin-like | 1.58e-03 | 6 | 195 | 2 | IPR022164 | |
| Domain | EFG_III-V | 1.58e-03 | 6 | 195 | 2 | IPR009022 | |
| Domain | EFG_C | 1.58e-03 | 6 | 195 | 2 | SM00838 | |
| Domain | Kinesin_assoc | 1.58e-03 | 6 | 195 | 2 | IPR032405 | |
| Domain | DUF3694 | 1.58e-03 | 6 | 195 | 2 | PF12473 | |
| Domain | EGF-like_CS | 1.73e-03 | 261 | 195 | 9 | IPR013032 | |
| Domain | EGF_CA | 1.78e-03 | 122 | 195 | 6 | SM00179 | |
| Domain | EGF_2 | 1.92e-03 | 265 | 195 | 9 | PS01186 | |
| Domain | EGF-like_Ca-bd_dom | 1.93e-03 | 124 | 195 | 6 | IPR001881 | |
| Domain | TYR_PHOSPHATASE_1 | 2.07e-03 | 86 | 195 | 5 | PS00383 | |
| Domain | ConA-like_dom | 2.17e-03 | 219 | 195 | 8 | IPR013320 | |
| Domain | TYR_PHOSPHATASE_dom | 2.18e-03 | 87 | 195 | 5 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 2.18e-03 | 87 | 195 | 5 | PS50056 | |
| Domain | - | 2.20e-03 | 7 | 195 | 2 | 3.30.70.240 | |
| Domain | EFG_V | 2.20e-03 | 7 | 195 | 2 | IPR000640 | |
| Domain | VWA | 2.77e-03 | 56 | 195 | 4 | PF00092 | |
| Domain | - | 2.78e-03 | 92 | 195 | 5 | 3.90.190.10 | |
| Domain | DHC_N1 | 2.91e-03 | 8 | 195 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 2.91e-03 | 8 | 195 | 2 | IPR013594 | |
| Domain | FHA | 3.03e-03 | 28 | 195 | 3 | SM00240 | |
| Domain | EGF | 3.34e-03 | 235 | 195 | 8 | SM00181 | |
| Domain | FN3 | 3.35e-03 | 185 | 195 | 7 | SM00060 | |
| Domain | Retrov_capsid_C | 3.35e-03 | 59 | 195 | 4 | IPR008916 | |
| Domain | PTPc_motif | 3.35e-03 | 59 | 195 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 3.35e-03 | 59 | 195 | 4 | IPR003595 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.08e-06 | 102 | 146 | 9 | M27648 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | KIF25 KIF13B COG2 CAPZA1 CAPZA2 VPS54 ARF1 ARF3 ARF4 ARF5 TUBAL3 | 8.46e-06 | 203 | 146 | 11 | M27654 |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 1.04e-05 | 134 | 146 | 9 | M27751 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.84e-05 | 110 | 146 | 8 | MM15350 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 3.51e-05 | 156 | 146 | 9 | M27097 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 7.93e-05 | 100 | 146 | 7 | M27650 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 1.42e-04 | 187 | 146 | 9 | M961 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND | 1.44e-04 | 77 | 146 | 6 | M41822 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 1.54e-04 | 189 | 146 | 9 | MM15356 | |
| Pubmed | ACLY EFTUD2 FAT2 KDR EEA1 VARS1 DSP FAT3 LINGO2 OGDH IGF2BP1 SNX25 TMPO KIF13A TOP2A | 1.08e-11 | 234 | 204 | 15 | 36243803 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.15e-09 | 4 | 204 | 4 | 10469592 | |
| Pubmed | 1.15e-09 | 4 | 204 | 4 | 7983737 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ACLY EFTUD2 GUF1 AP1G1 EEA1 FKBP4 DSP DYNC2H1 OGDH ARF1 ARF3 ARF4 ARF5 DNAH1 PTPA ERLIN2 THOP1 CNDP2 RBM46 MYO15A CTSD CNOT1 | 2.80e-09 | 807 | 204 | 22 | 30575818 |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-19 ERVK-24 ERVK-8 ERVK-5 | 4.76e-09 | 94 | 204 | 9 | 21542922 |
| Pubmed | 5.06e-09 | 12 | 204 | 5 | 14557543 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 5.72e-09 | 5 | 204 | 4 | 12629516 | |
| Pubmed | ADP-ribosylation factor is functionally and physically associated with the Golgi complex. | 5.72e-09 | 5 | 204 | 4 | 2105501 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ARHGAP32 WASHC2A LRP1B NUP205 ESYT2 CPLANE1 FKBP4 CCHCR1 RPGRIP1L DRG2 WASHC2C DSP CAPZA1 SORBS1 CEP192 ARF1 ARF3 CKAP2 EIF2A CNOT1 TOP2A EXOC4 | 7.63e-09 | 853 | 204 | 22 | 28718761 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | EFTUD2 ADSL VARS1 DRG2 BAG3 CAPZA2 VAT1L OGDH JMJD1C ARF1 ARF4 ARF5 ERLIN2 COPS4 CSTF2 TMPO CNOT1 TOP2A TUBAL3 | 1.71e-08 | 665 | 204 | 19 | 30457570 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ACLY NUP205 EFTUD2 SCAF1 ADSL AP1G1 EEA1 VARS1 FKBP4 DNAH10 DSP DYNC2H1 CAPZA1 CAPZA2 CARS1 MSH3 OGDH ARF1 ARF4 IGF2BP1 THADA ERLIN2 COPS4 TMPO CTSD ATP2B1 CNOT1 TOP2A | 2.30e-08 | 1425 | 204 | 28 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ACLY NUP205 EFTUD2 GUF1 ADSL AP1G1 ASCC3 MVP VARS1 FNDC3B DSC3 EP400 DSP TBPL1 BAG3 CAPZA1 POLR2H CAPZA2 ATL3 MSH3 ARF4 MRPS15 EIF2A CTSD ATP2B1 TOP2A EXOC4 | 3.07e-08 | 1353 | 204 | 27 | 29467282 |
| Pubmed | 3.97e-08 | 7 | 204 | 4 | 16059920 | ||
| Pubmed | 7.90e-08 | 8 | 204 | 4 | 8947846 | ||
| Pubmed | 7.90e-08 | 8 | 204 | 4 | 8195219 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ACLY SCYL1 WASHC2A NUP205 EFTUD2 ADSL AP1G1 GMDS MVP VARS1 FKBP4 DRG2 BAG3 CAPZA1 POLR2H CAPZA2 CARS1 GDA NMI THOP1 COPS4 CNDP2 CSTF2 EIF2A KIF13A CNOT1 GABPA | 1.33e-07 | 1455 | 204 | 27 | 22863883 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ACLY PDZK1 ITGA1 ADGRV1 EEA1 ALDH3B1 MVP ALOX12 FKBP4 COL6A3 DSP DYNC2H1 CAPZA1 CAPZA2 APCS ABCC11 GSTCD CNDP2 ABCB11 MYO15A IL1RN CTSD | 1.63e-07 | 1016 | 204 | 22 | 19056867 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ACLY INSR NUP205 EFTUD2 SCAF1 PTPRF EEA1 ASCC3 VARS1 FKBP4 EP400 DSP CAPZA1 CAPZA2 ARF1 IGF2BP1 CSTF2 CKAP2L TMPO ATP2B1 CNOT1 TOP2A | 1.86e-07 | 1024 | 204 | 22 | 24711643 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ACLY PIEZO1 ITGA1 LRP1B IGSF10 ADSL PTPRF PTPRK SGCE NENF DSE FAT4 AGPAT2 CELSR1 THADA ERLIN2 SCAP LOXL1 COPS4 TMPO CKAP2 CTSD ATP2B1 DGAT1 | 1.87e-07 | 1201 | 204 | 24 | 35696571 |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 23783033 | ||
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 1447192 | ||
| Pubmed | 2.35e-07 | 10 | 204 | 4 | 10828067 | ||
| Pubmed | ACLY SPART EFTUD2 ESYT2 AP1G1 MOCS3 VARS1 COG2 WASHC2C MSH3 NFS1 TMPO CKAP2 CNOT1 TOP2A EXOC4 | 2.40e-07 | 560 | 204 | 16 | 35241646 | |
| Pubmed | 3.66e-07 | 77 | 204 | 7 | 10835267 | ||
| Pubmed | MAGI1 ACLY INSR EFTUD2 ADSL ASCC3 GPT2 MVP VARS1 FKBP4 VPS18 BAG3 CAPZA1 POLR2H CAPZA2 ARF1 ARF4 DNAH1 ERLIN2 THOP1 MRPS15 CNDP2 TMPO TOP2A | 3.68e-07 | 1247 | 204 | 24 | 27684187 | |
| Pubmed | 5.48e-07 | 12 | 204 | 4 | 30631079 | ||
| Pubmed | PIEZO1 SPART WASHC2A EFTUD2 GUF1 ESYT2 GMDS ASCC3 FKBP4 NENF DRG2 DSC3 DYNC2H1 BAG3 SPG11 CEP192 NFS1 OGDH THADA COPS4 CNDP2 TMPO CKAP2 EIF2A ATP2B1 EXOC4 | 7.15e-07 | 1487 | 204 | 26 | 33957083 | |
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 8491770 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAGI1 ARHGAP32 ESYT2 SYDE2 KIF13B SORBS2 DRG2 DSP BAG3 SORBS1 CEP192 PTPN21 ARF4 SH3D19 PLEKHM3 CKAP2 KIF13A ATP2B1 EXOC4 | 9.00e-07 | 861 | 204 | 19 | 36931259 |
| Pubmed | MAGI1 ARHGAP32 ACLY SPART ESYT2 ASCC3 DSC3 DSP CAPZA1 JMJD1C ARF3 SH3D19 TMPO EIF2A ATP2B1 CNOT1 EXOC4 | 1.12e-06 | 708 | 204 | 17 | 39231216 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | NUP205 GUF1 PTPRA PTPRF SGCE EXOG EEA1 COG2 VPS18 DSC3 DYNC2H1 BAG3 RNF8 SPG11 OGDH THADA PTPA SCAP COPS4 CNDP2 EIF2A | 1.34e-06 | 1061 | 204 | 21 | 33845483 |
| Pubmed | ARHGAP32 EFTUD2 FAT2 CSTF2T KIF13B VPS18 DYNC2H1 RNF8 FANCM JMJD1C GDA THADA SCAP EXOC4 | 1.49e-06 | 493 | 204 | 14 | 15368895 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ACLY ITGA1 EFTUD2 GUF1 ESYT2 ADSL AP1G1 PTPRK LOXL3 GPT2 VARS1 FNDC3B DSP TBPL1 ATL3 NFS1 OGDH ARF3 ARF4 ARF5 ERLIN2 THOP1 LOXL1 MRPS15 ATP2B1 | 1.55e-06 | 1451 | 204 | 25 | 30550785 |
| Pubmed | USP9X Deubiquitylates DVL2 to Regulate WNT Pathway Specification. | 1.77e-06 | 62 | 204 | 6 | 31340145 | |
| Pubmed | MAGI1 ARHGAP32 ADGRV1 EXOG SORBS2 RAP2A CAPZA1 CAPZA2 SORBS1 ARF3 TNR ATP2B1 TUBAL3 | 1.80e-06 | 430 | 204 | 13 | 32581705 | |
| Pubmed | ETS1 WASHC2A AP1G1 EXOC3L4 HSD3B1 CPLANE1 DSE MRTFA KIF13B CCHCR1 WASHC2C ZNF212 CAPZA2 CEP192 THOP1 SCAP CSTF2 CKAP2 KIF13A ATP2B1 CNOT1 | 1.87e-06 | 1084 | 204 | 21 | 11544199 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ACLY NUP205 IGSF10 SCAF1 SYDE2 EXOC3L4 DSE PLXNB3 FAT4 DSP PCDHA5 ARF5 CSTF2 TMPO TNR RPE65 CNOT1 | 1.88e-06 | 736 | 204 | 17 | 29676528 |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.97e-06 | 5 | 204 | 3 | 11401426 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 9038142 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SPART WASHC2A KIF13B RPGRIP1L WASHC2C EP400 DSP DYNC2H1 CAPZA1 CAPZA2 RNF8 SORBS1 CEP192 SENP6 EXOC4 | 2.34e-06 | 588 | 204 | 15 | 38580884 |
| Pubmed | 2.47e-06 | 37 | 204 | 5 | 16396496 | ||
| Pubmed | SCYL1 NUP205 PTPRF AP1G1 MRTFA FAT4 RAP2A EP400 DSP DYNC2H1 CAPZA1 SCAP COPS4 KIF13A IL1RN CTSD EXOC4 | 2.60e-06 | 754 | 204 | 17 | 35906200 | |
| Pubmed | 3.30e-06 | 18 | 204 | 4 | 18664271 | ||
| Pubmed | Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development. | 3.30e-06 | 18 | 204 | 4 | 33108146 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ACLY NUP205 EFTUD2 SCAF1 GUF1 ESYT2 ASCC3 VARS1 DRG2 EP400 TBPL1 POLR2H CAPZA2 ATL3 ARF3 ARF4 ARF5 IGF2BP1 CNDP2 TMPO TOP2A TUBAL3 GABPA | 3.40e-06 | 1318 | 204 | 23 | 30463901 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | NUP205 ADSL EEA1 VARS1 FKBP4 BAG3 CAPZA1 OGDH ARF1 ARF3 IGF2BP1 CSTF2 EIF2A CTSD TOP2A | 3.44e-06 | 607 | 204 | 15 | 39147351 |
| Pubmed | An Arf/Rab cascade controls the growth and invasiveness of glioblastoma. | 3.93e-06 | 6 | 204 | 3 | 33443570 | |
| Pubmed | WLS retrograde transport to the endoplasmic reticulum during Wnt secretion. | 3.93e-06 | 6 | 204 | 3 | 24768165 | |
| Pubmed | 3.93e-06 | 6 | 204 | 3 | 15063128 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | NUP205 AP1G1 ASCC3 FKBP4 KIF13B DRG2 TBPL1 CAPZA2 MSH3 ARF4 IGF2BP1 MRPS15 EIF2A CNOT1 TOP2A EXOC4 | 4.68e-06 | 704 | 204 | 16 | 29955894 |
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | 5.11e-06 | 271 | 204 | 10 | 25737280 | |
| Pubmed | ACLY ASCC3 CSTF2T EP400 DSP BAG3 CAPZA1 JMJD1C SH3D19 CSTF2 TMPO CNOT1 TOP2A EXOC4 | 5.15e-06 | 549 | 204 | 14 | 38280479 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ACLY SPART NUP205 EFTUD2 ESYT2 ADSL GMDS ASCC3 VARS1 DSP CAPZA1 POLR2H CAPZA2 ARF1 ARF3 ARF4 ARF5 IGF2BP1 NMI ERLIN2 TMPO CNOT1 | 5.37e-06 | 1257 | 204 | 22 | 37317656 |
| Pubmed | 6.84e-06 | 7 | 204 | 3 | 11950392 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | ACLY PABPC5 ESYT2 MVP DSP BAG3 CAPZA1 CAPZA2 ABCC11 ARF4 THADA CTSD ATP2B1 TOP2A EXOC4 | 7.39e-06 | 647 | 204 | 15 | 26618866 |
| Pubmed | DCHS2 SPTB LRP1B GUF1 PTPRA PTPRK MVP VARS1 PLXNB3 COG2 SORBS2 DSP CAPZA2 SORBS1 MSH3 VPS54 THOP1 SH3D19 COPS4 SENP6 CKAP2 EXOC4 | 7.59e-06 | 1285 | 204 | 22 | 35914814 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 7.92e-06 | 80 | 204 | 6 | 10716726 | |
| Pubmed | Substrate-trapping techniques in the identification of cellular PTP targets. | 1.02e-05 | 49 | 204 | 5 | 15588985 | |
| Pubmed | 1.03e-05 | 360 | 204 | 11 | 33111431 | ||
| Pubmed | Coated vesicle assembly in the Golgi requires only coatomer and ARF proteins from the cytosol. | 1.09e-05 | 8 | 204 | 3 | 8355790 | |
| Pubmed | 1.09e-05 | 8 | 204 | 3 | 11926829 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | ARHGAP32 ETS1 EFTUD2 CEACAM21 SYDE2 COL6A3 ARF1 THOP1 CNDP2 TMPO ATP2B1 | 1.11e-05 | 363 | 204 | 11 | 14691545 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ACLY SPART EFTUD2 FKBP4 WASHC2C EP400 DSP BAG3 CAPZA1 CAPZA2 IGF2BP1 SH3D19 COPS4 SENP6 TMPO CKAP2 EIF2A TOP2A | 1.13e-05 | 934 | 204 | 18 | 33916271 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ACLY SCYL1 NUP205 ESYT2 PTPRF AP1G1 PTPRK ASCC3 VARS1 DYNC2H1 BAG3 ARF4 THADA ERLIN2 SCAP CSTF2 TMPO EXOC4 | 1.27e-05 | 942 | 204 | 18 | 31073040 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | PDZK1 HDAC8 PFKFB4 WASHC2A ADCY2 ELMO1 GMDS ALDH3B1 PLXNB3 DMGDH KIF13B COG2 RPGRIP1L WASHC2C DUSP3 CAPZA2 OGDH JMJD1C GDA ERLIN2 MYO15A | 1.49e-05 | 1242 | 204 | 21 | 30973865 |
| Pubmed | ARHGAP32 ESYT2 PTPRA PTPRF PTPRK FKBP4 RPGRIP1L DSC3 DSP BAG3 CEP192 PTPN21 CNNM1 PTPA CSTF2 TMPO CKAP2 ATP2B1 CNOT1 | 1.52e-05 | 1049 | 204 | 19 | 27880917 | |
| Pubmed | INSR SCYL1 EFTUD2 SYDE2 FAT4 RPGRIP1L EP400 CEP192 ARF1 ARF3 ARF4 ARF5 IGF2BP1 THADA ERLIN2 TMPO | 1.59e-05 | 777 | 204 | 16 | 35844135 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | ACLY NUP205 ESYT2 PTPRA ADSL PTPRF PTPRK ASCC3 VARS1 DUSP3 BAG3 ATL3 PTPN21 IGF2BP1 ERLIN2 THOP1 EIF2A ATP2B1 | 1.97e-05 | 974 | 204 | 18 | 28675297 |
| Pubmed | ACLY SCYL1 ITGA1 ELMO1 NUP205 EFTUD2 ESYT2 AP1G1 ASCC3 MVP DRG2 PHRF1 ATL3 MSH3 ARF4 TMPO ARHGAP45 ATP2B1 CNOT1 EXOC4 | 2.01e-05 | 1168 | 204 | 20 | 19946888 | |
| Pubmed | 2.30e-05 | 257 | 204 | 9 | 16335952 | ||
| Pubmed | 2.31e-05 | 10 | 204 | 3 | 12970426 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NUP205 EFTUD2 PCDH15 MVP VARS1 CSTF2T SORBS2 EP400 DSP AGPAT2 POLR2H OGDH ARF4 IGF2BP1 MRPS15 CSTF2 TMPO CNOT1 TNXB | 2.32e-05 | 1082 | 204 | 19 | 38697112 |
| Pubmed | ACLY SCYL1 EFTUD2 MVP VARS1 FKBP4 DRG2 DSP BAG3 CAPZA1 CAPZA2 ARF4 ARF5 CNDP2 CTSD TOP2A | 2.36e-05 | 803 | 204 | 16 | 36517590 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAGI1 CDH26 SPTB INSR HDAC8 PFKFB4 ADGRV1 ESYT2 GPT2 ZNF449 CAPZA1 CEP192 VPS54 OGDH JMJD1C DNAH1 THADA THOP1 CNDP2 CKAP2 ATP2B1 CNOT1 EXOC4 | 2.40e-05 | 1489 | 204 | 23 | 28611215 |
| Pubmed | 2.56e-05 | 59 | 204 | 5 | 20855565 | ||
| Pubmed | 2.62e-05 | 146 | 204 | 7 | 27068509 | ||
| Pubmed | 3.17e-05 | 11 | 204 | 3 | 7832766 | ||
| Pubmed | ACLY INSR PTPRA MVP FKBP4 DSP CAPZA1 CAPZA2 ARF1 ARF3 ARF4 CNDP2 ATP2B1 | 3.28e-05 | 565 | 204 | 13 | 20458337 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 10779520 | ||
| Pubmed | Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein. | 3.42e-05 | 2 | 204 | 2 | 12773396 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 21852673 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 11158333 | ||
| Pubmed | Human ADP-ribosylation factors. A functionally conserved family of GTP-binding proteins. | 3.42e-05 | 2 | 204 | 2 | 1899243 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 25085622 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 24940003 | ||
| Pubmed | Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1. | 3.42e-05 | 2 | 204 | 2 | 11956242 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 20827171 | ||
| Pubmed | SENP6-Mediated deSUMOylation of VEGFR2 Enhances Its Cell Membrane Transport in Angiogenesis. | 3.42e-05 | 2 | 204 | 2 | 36768878 | |
| Pubmed | FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans. | 3.42e-05 | 2 | 204 | 2 | 36717248 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 16621515 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 1577740 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 8661066 | ||
| Pubmed | Hyperleptinemia is not responsible for decreased paraoxonase activity in hemodialysis patients. | 3.42e-05 | 2 | 204 | 2 | 16534235 | |
| Pubmed | IFP35 family proteins promote neuroinflammation and multiple sclerosis. | 3.42e-05 | 2 | 204 | 2 | 34362845 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 1321126 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 33853613 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 12130553 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 14681198 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 9060628 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 24997994 | ||
| Interaction | LAMTOR1 interactions | INSR SPART WASHC2A ESYT2 PTPRF AP1G1 EXOG EEA1 SNX12 FKBP4 KIF13B VPS18 WASHC2C DSC3 BAG3 CAPZA2 SPG11 CEP192 VPS54 ARF1 ARF3 ARF4 ARF5 PLEKHM3 ATP2B1 EXOC4 | 1.25e-08 | 722 | 199 | 26 | int:LAMTOR1 |
| Interaction | B4GALT2 interactions | 2.82e-06 | 119 | 199 | 9 | int:B4GALT2 | |
| Interaction | CD160 interactions | 7.47e-06 | 48 | 199 | 6 | int:CD160 | |
| Interaction | RYK interactions | INSR PTPRA PTPRF CEACAM21 PTPRK SGCE FAT4 DSC3 FAT3 CNNM1 CELSR1 | 8.79e-06 | 212 | 199 | 11 | int:RYK |
| Interaction | AGR2 interactions | MAGI1 ACLY EFTUD2 GUF1 AP1G1 EEA1 FKBP4 DSP DYNC2H1 OGDH ARF1 ARF3 ARF4 ARF5 DNAH1 PTPA ERLIN2 THOP1 CNDP2 RBM46 CKAP2 MYO15A CTSD CNOT1 | 1.79e-05 | 934 | 199 | 24 | int:AGR2 |
| Interaction | CLN3 interactions | 1.88e-05 | 115 | 199 | 8 | int:CLN3 | |
| Interaction | CTNNB1 interactions | MAGI1 ARHGAP32 ACLY EFTUD2 PTPRA ADSL PTPRF PTPRK PTPRQ KDR FKBP4 SORBS2 DSC3 EP400 CAPZA1 POLR2H CAPZA2 RNF8 ABCC11 SORBS1 ARF1 IGF2BP1 PTPA TMPO TOP2A | 2.18e-05 | 1009 | 199 | 25 | int:CTNNB1 |
| Interaction | GGA1 interactions | 2.72e-05 | 121 | 199 | 8 | int:GGA1 | |
| Interaction | RAB4A interactions | WASHC2A ESYT2 EEA1 KIF13B VPS18 WASHC2C BAG3 VPS54 ARF1 ARF4 CNDP2 TMPO KIF13A ATP2B1 EXOC4 | 5.16e-05 | 457 | 199 | 15 | int:RAB4A |
| Interaction | IFITM1 interactions | SPTB SPART WASHC2A PTPRF AP1G1 EEA1 SNX12 WASHC2C DSC3 MSH3 ERLIN2 TOP2A EXOC4 | 5.50e-05 | 355 | 199 | 13 | int:IFITM1 |
| Interaction | C2CD4B interactions | 7.09e-05 | 44 | 199 | 5 | int:C2CD4B | |
| Interaction | SLC2A4 interactions | 7.81e-05 | 72 | 199 | 6 | int:SLC2A4 | |
| Interaction | EED interactions | ACLY HDAC8 SCYL1 NUP205 EFTUD2 AP1G1 ASCC3 MVP SNX12 VARS1 VPS18 DRG2 EP400 DSP DUSP3 CAPZA1 POLR2H CAPZA2 MSH3 ARF3 ARF4 IGF2BP1 THADA ERLIN2 THOP1 XIRP2 CNDP2 TMPO CNOT1 TOP2A | 8.65e-05 | 1445 | 199 | 30 | int:EED |
| Interaction | COPZ1 interactions | 8.94e-05 | 143 | 199 | 8 | int:COPZ1 | |
| Interaction | ARCN1 interactions | 9.35e-05 | 228 | 199 | 10 | int:ARCN1 | |
| Interaction | ATXN1 interactions | ARHGAP32 EFTUD2 ADSL VARS1 FAT4 DRG2 WASHC2C BAG3 CAPZA2 VAT1L OGDH JMJD1C ARF1 ARF4 ARF5 ERLIN2 LOXL1 COPS4 CSTF2 TMPO SORCS3 CNOT1 TOP2A TUBAL3 | 9.65e-05 | 1039 | 199 | 24 | int:ATXN1 |
| Interaction | PTPRQ interactions | 9.92e-05 | 25 | 199 | 4 | int:PTPRQ | |
| GeneFamily | Cadherin related | 1.15e-07 | 17 | 133 | 5 | 24 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.52e-05 | 21 | 133 | 4 | 813 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 7.55e-05 | 31 | 133 | 4 | 357 | |
| GeneFamily | Fibronectin type III domain containing | 1.82e-04 | 160 | 133 | 7 | 555 | |
| GeneFamily | WASH complex | 7.90e-04 | 6 | 133 | 2 | 1331 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.23e-03 | 161 | 133 | 6 | 593 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 2.83e-03 | 11 | 133 | 2 | 1168 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 LRP1B PTPRQ PCDH11X PCDH15 FAT4 DNAH10 FAT3 DNAH1 XIRP2 DGKK MYO15A | 3.56e-11 | 184 | 195 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 LRP1B PTPRQ PCDH11X PCDH15 FAT4 DNAH10 FAT3 DNAH1 XIRP2 DGKK MYO15A | 3.56e-11 | 184 | 195 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 LRP1B PTPRQ PCDH11X PCDH15 FAT4 DNAH10 FAT3 DNAH1 XIRP2 DGKK MYO15A | 3.56e-11 | 184 | 195 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.53e-07 | 188 | 195 | 9 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ADGRV1 IGSF10 PTPRF VWA3B CPLANE1 IQUB DNAH10 DYNC2H1 CELSR1 | 1.91e-07 | 193 | 195 | 9 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.18e-07 | 196 | 195 | 9 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 2.28e-07 | 197 | 195 | 9 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-07 | 198 | 195 | 9 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-07 | 198 | 195 | 9 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.48e-07 | 199 | 195 | 9 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.48e-07 | 199 | 195 | 9 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.06e-07 | 171 | 195 | 8 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 2.00e-06 | 190 | 195 | 8 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 192 | 195 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.24e-06 | 193 | 195 | 8 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-06 | 194 | 195 | 8 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.42e-06 | 195 | 195 | 8 | f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.52e-06 | 196 | 195 | 8 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.92e-06 | 200 | 195 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.92e-06 | 200 | 195 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-dn_T|IIF / Disease, condition lineage and cell class | 2.92e-06 | 200 | 195 | 8 | c34fff02992cba6bcc2308019cb00b94e1227300 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.92e-06 | 200 | 195 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.92e-06 | 200 | 195 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.92e-06 | 200 | 195 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.70e-06 | 151 | 195 | 7 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.82e-06 | 156 | 195 | 7 | 203ef22eb76bd2b829b027c30af0557080f4006c | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.16e-06 | 161 | 195 | 7 | 8de421c61f4d5a6e05fdb20e4d230e2db98ee4d5 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.46e-06 | 162 | 195 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.46e-06 | 168 | 195 | 7 | 1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.46e-06 | 168 | 195 | 7 | 69f534de0f9a293047bea03cb1b78551087a8df5 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-06 | 169 | 195 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.06e-05 | 113 | 195 | 6 | 0651fb7a7e1ea84b8365059e5ed85bf6c082da1a | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8-MURAL_Mural.Acta2Rgs5.Kcnj8-Abcc9_(Mural.Acta2Rgs5.Kcnj8-Abcc9)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.06e-05 | 113 | 195 | 6 | 0e153efddd061d7510dfc3859cc8b1a7984fa70e | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-05 | 174 | 195 | 7 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 176 | 195 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 176 | 195 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 177 | 195 | 7 | 092a345cb802f183322aa5542341ba2d96d4f06a | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 177 | 195 | 7 | 7ac99ff16df94b4e08d361e3d98a7b3af8d6ee3b | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 179 | 195 | 7 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.48e-05 | 180 | 195 | 7 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 180 | 195 | 7 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 184 | 195 | 7 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-05 | 184 | 195 | 7 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 186 | 195 | 7 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.89e-05 | 187 | 195 | 7 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.89e-05 | 187 | 195 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.89e-05 | 187 | 195 | 7 | 8e8b147258982b359447add5027318f5b6d51963 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.96e-05 | 188 | 195 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 189 | 195 | 7 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.03e-05 | 189 | 195 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 190 | 195 | 7 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 2.10e-05 | 190 | 195 | 7 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 190 | 195 | 7 | 2abeb013bb83c578e67dcb985ba44ca63134950b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.17e-05 | 191 | 195 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 191 | 195 | 7 | d1205aab0937f2becfcd239610e9b78fb8a0c886 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 2.17e-05 | 191 | 195 | 7 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 2.17e-05 | 191 | 195 | 7 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.24e-05 | 192 | 195 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Ciliated-cil-3|World / Class top | 2.24e-05 | 192 | 195 | 7 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 192 | 195 | 7 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 192 | 195 | 7 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.24e-05 | 192 | 195 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.24e-05 | 129 | 195 | 6 | 856255fbfc7f95642000cfd7704141b2388f7c5c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-05 | 194 | 195 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.40e-05 | 194 | 195 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 195 | 195 | 7 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 2.48e-05 | 195 | 195 | 7 | 6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.48e-05 | 195 | 195 | 7 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.48e-05 | 195 | 195 | 7 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 2.48e-05 | 195 | 195 | 7 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.48e-05 | 195 | 195 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.48e-05 | 195 | 195 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 195 | 195 | 7 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 195 | 195 | 7 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.56e-05 | 196 | 195 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.56e-05 | 196 | 195 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.64e-05 | 197 | 195 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.64e-05 | 197 | 195 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.64e-05 | 197 | 195 | 7 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 198 | 195 | 7 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-05 | 198 | 195 | 7 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.73e-05 | 198 | 195 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.73e-05 | 198 | 195 | 7 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | facs-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-05 | 198 | 195 | 7 | e85ae846e293687fd193f4d565525d8d3bd1faea | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 199 | 195 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.82e-05 | 199 | 195 | 7 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.82e-05 | 199 | 195 | 7 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 199 | 195 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 199 | 195 | 7 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 199 | 195 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.82e-05 | 199 | 195 | 7 | 2b9e1e069b36b3a61cc3e384f4523687b0e03905 | |
| ToppCell | facs-Heart-RV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 135 | 195 | 6 | 1fe684ed5913ae757ad6befbbe12d1bee481dd12 | |
| ToppCell | facs-Heart-RV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 135 | 195 | 6 | 99e7ac9b1139fe4ff036f6f048a8f1cc514c1fb9 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 2.91e-05 | 200 | 195 | 7 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.91e-05 | 200 | 195 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 2.91e-05 | 200 | 195 | 7 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.91e-05 | 200 | 195 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 2.91e-05 | 200 | 195 | 7 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.91e-05 | 200 | 195 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.15e-05 | 137 | 195 | 6 | a69976938d4e89315ec0be3a332b91ddf3799d65 | |
| Drug | orthovanadate | INSR PFKFB4 KIF25 HJV KIF13B DUSP3 LEP SLC2A2 DNAH1 PTPA GSTCD PRKACG ABCB11 KIF13A CTSD ATP2B1 | 1.34e-06 | 435 | 197 | 16 | CID000061672 |
| Drug | lecithin | ACLY ATP8A2 PDZK1 LOXL3 ALOX12 PON1 ARF1 ARF3 ARF4 ARF5 LOXL1 ABCB11 RPE65 | 2.77e-06 | 305 | 197 | 13 | CID010425705 |
| Disease | cognitive function measurement, self reported educational attainment | PFKFB4 FBXL4 PTPRF EEA1 MRTFA JMJD1C IGF2BP1 SH3D19 SORCS3 TNXB EXOC4 | 1.81e-05 | 355 | 187 | 11 | EFO_0004784, EFO_0008354 |
| Disease | mean platelet volume | ARHGAP32 PFKFB4 ELMO1 ESYT2 EXOC3L4 MVP ALOX12 DSE MRTFA PCDHGB7 PCDHGA10 CAPZA1 CAPZA2 SORBS1 JMJD1C GALNT9 CKAP2L CD72 ARHGAP45 | 2.85e-05 | 1020 | 187 | 19 | EFO_0004584 |
| Disease | Squamous cell carcinoma of esophagus | 3.26e-05 | 95 | 187 | 6 | C0279626 | |
| Disease | C-glycosyltryptophan-to-succinylcarnitine ratio | 4.00e-05 | 2 | 187 | 2 | EFO_0021416 | |
| Disease | Prostatic Neoplasms | CYP19A1 PDZK1 LRP1B PTPRK HSD3B1 CCHCR1 PON1 MSH3 LEP GSTCD SENP6 IL1RN CTSD TOP2A | 4.21e-05 | 616 | 187 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | CYP19A1 PDZK1 LRP1B PTPRK HSD3B1 CCHCR1 PON1 MSH3 LEP GSTCD SENP6 IL1RN CTSD TOP2A | 4.21e-05 | 616 | 187 | 14 | C0376358 |
| Disease | testosterone measurement | MAGI1 DCHS2 CYP19A1 INSR ETS1 PTPRF PTRHD1 GMDS VARS1 FKBP4 DRG2 CAPZA1 LINGO2 PTPN21 JMJD1C THADA THOP1 DGKK PLEKHM3 MYO15A RPE65 | 6.36e-05 | 1275 | 187 | 21 | EFO_0004908 |
| Disease | Ciliopathies | 7.42e-05 | 110 | 187 | 6 | C4277690 | |
| Disease | Nodular glomerulosclerosis | 1.32e-04 | 41 | 187 | 4 | C0017667 | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 1.60e-04 | 17 | 187 | 3 | DOID:10873 (is_implicated_in) | |
| Disease | Diabetic Nephropathy | 1.74e-04 | 44 | 187 | 4 | C0011881 | |
| Disease | 2-methylmalonylcarnitine (C4-DC) measurement | 2.38e-04 | 4 | 187 | 2 | EFO_0800250 | |
| Disease | Fatty Liver | 2.48e-04 | 88 | 187 | 5 | C0015695 | |
| Disease | Steatohepatitis | 2.48e-04 | 88 | 187 | 5 | C2711227 | |
| Disease | neuroticism measurement, cognitive function measurement | LRP1B ADCY2 SCAF1 PTPRK ASCC3 PCDHA5 JMJD1C IGF2BP1 SCAP SORCS3 TNR EXOC4 | 2.83e-04 | 566 | 187 | 12 | EFO_0007660, EFO_0008354 |
| Disease | peak expiratory flow | ITGA1 PTPRF PTPRK GMDS KDR FKBP4 MRTFA DMGDH FNDC3B THADA GSTCD | 3.59e-04 | 498 | 187 | 11 | EFO_0009718 |
| Disease | reticulocyte count | ACLY CYP19A1 PIEZO1 SPTB INSR ITGA1 ITGAD PTPRA GMDS CCHCR1 FNDC3B DNAH10 JMJD1C THADA SLC9A5 ARHGAP45 ATP2B1 | 3.76e-04 | 1045 | 187 | 17 | EFO_0007986 |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 3.90e-04 | 97 | 187 | 5 | DOID:3083 (is_marker_for) | |
| Disease | 2'-O-methyluridine measurement | 3.95e-04 | 5 | 187 | 2 | EFO_0800636 | |
| Disease | acyl-CoA-binding domain-containing protein 7 measurement | 3.95e-04 | 5 | 187 | 2 | EFO_0801343 | |
| Disease | hemoglobin A1 measurement | PIEZO1 SPTB ITGAD PTPRA FNDC3B JMJD1C SLC2A2 THADA PTPA ABCB11 DGAT1 | 5.15e-04 | 520 | 187 | 11 | EFO_0007629 |
| Disease | fasting blood glucose measurement | 5.17e-04 | 287 | 187 | 8 | EFO_0004465 | |
| Disease | Neonatal diabetes mellitus | 5.20e-04 | 25 | 187 | 3 | C0158981 | |
| Disease | Microvascular complications of diabetes, susceptibility | 5.89e-04 | 6 | 187 | 2 | cv:CN357508 | |
| Disease | non-alcoholic fatty liver disease (is_marker_for) | 6.55e-04 | 27 | 187 | 3 | DOID:0080208 (is_marker_for) | |
| Disease | free androgen index | 6.74e-04 | 374 | 187 | 9 | EFO_0007005 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 8.01e-04 | 171 | 187 | 6 | DOID:9352 (is_implicated_in) | |
| Disease | Crohn's disease (is_marker_for) | 8.11e-04 | 29 | 187 | 3 | DOID:8778 (is_marker_for) | |
| Disease | immature platelet fraction | 8.14e-04 | 114 | 187 | 5 | EFO_0009187 | |
| Disease | cognitive function measurement | MAGI1 PIEZO1 LRP1B ADCY2 FBXL4 PTPRF VWA3B EEA1 MRTFA DSP LINGO2 CEP192 JMJD1C IGF2BP1 SORCS3 RBM46 TNR TNXB GABPA EXOC4 | 8.16e-04 | 1434 | 187 | 20 | EFO_0008354 |
| Disease | hereditary lymphedema (is_implicated_in) | 8.22e-04 | 7 | 187 | 2 | DOID:0050580 (is_implicated_in) | |
| Disease | hypersomnia | 8.22e-04 | 7 | 187 | 2 | EFO_0005246 | |
| Disease | osteoporosis (is_implicated_in) | 9.88e-04 | 31 | 187 | 3 | DOID:11476 (is_implicated_in) | |
| Disease | Henoch-Schoenlein purpura (is_implicated_in) | 1.09e-03 | 8 | 187 | 2 | DOID:11123 (is_implicated_in) | |
| Disease | HDL cholesterol change measurement, response to simvastatin, response to fenofibrate | 1.09e-03 | 8 | 187 | 2 | EFO_0007805, GO_1901557, GO_1903491 | |
| Disease | exfoliation syndrome (is_marker_for) | 1.09e-03 | 8 | 187 | 2 | DOID:13641 (is_marker_for) | |
| Disease | Alcohol withdrawal syndrome | 1.09e-03 | 8 | 187 | 2 | C0236663 | |
| Disease | breast cancer (is_marker_for) | 1.20e-03 | 185 | 187 | 6 | DOID:1612 (is_marker_for) | |
| Disease | HbA1c measurement | PIEZO1 SPTB ITGAD FNDC3B MED30 LEP SLC2A2 THADA ABCB11 MYO15A ARHGAP45 DGAT1 | 1.32e-03 | 675 | 187 | 12 | EFO_0004541 |
| Disease | alcohol dependence (implicated_via_orthology) | 1.40e-03 | 9 | 187 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | Gestational Diabetes | 1.40e-03 | 9 | 187 | 2 | C0085207 | |
| Disease | cholestasis (implicated_via_orthology) | 1.40e-03 | 9 | 187 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 1.44e-03 | 261 | 187 | 7 | C0004352 | |
| Disease | chronic obstructive pulmonary disease | DCHS2 PIEZO1 ITGA1 VARS1 FNDC3B COL6A3 DSP BAG3 LINGO2 VPS54 GSTCD KIF13A | 1.54e-03 | 688 | 187 | 12 | EFO_0000341 |
| Disease | alpha wave measurement, electroencephalogram measurement | 1.74e-03 | 10 | 187 | 2 | EFO_0004357, EFO_0006870 | |
| Disease | myocardial infarction | 1.84e-03 | 350 | 187 | 8 | EFO_0000612 | |
| Disease | short-term memory | 1.94e-03 | 83 | 187 | 4 | EFO_0004335 | |
| Disease | ulcerative colitis (is_marker_for) | 2.08e-03 | 40 | 187 | 3 | DOID:8577 (is_marker_for) | |
| Disease | Diarrhea | 2.12e-03 | 11 | 187 | 2 | C0011991 | |
| Disease | bilirubin measurement | 2.14e-03 | 442 | 187 | 9 | EFO_0004570 | |
| Disease | FEV/FEC ratio | DCHS2 ITGA1 ADCY2 GMDS KDR MRTFA FNDC3B COL6A3 DSP BAG3 JMJD1C THADA GSTCD MYO15A KIF13A ATP2B1 TNXB | 2.18e-03 | 1228 | 187 | 17 | EFO_0004713 |
| Disease | Disorder of eye | 2.39e-03 | 212 | 187 | 6 | C0015397 | |
| Disease | carotid artery intima media thickness | 2.41e-03 | 450 | 187 | 9 | EFO_0007117 | |
| Disease | open-angle glaucoma (is_implicated_in) | 2.53e-03 | 12 | 187 | 2 | DOID:1067 (is_implicated_in) | |
| Disease | obesity (implicated_via_orthology) | 2.57e-03 | 215 | 187 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | cardiovascular disease | 2.67e-03 | 457 | 187 | 9 | EFO_0000319 | |
| Disease | Diabetes Mellitus, Non-Insulin-Dependent | 2.94e-03 | 221 | 187 | 6 | C0011860 | |
| Disease | diabetic angiopathy (is_implicated_in) | 2.98e-03 | 13 | 187 | 2 | DOID:11713 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.01e-03 | 222 | 187 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | glaucoma | 3.06e-03 | 154 | 187 | 5 | MONDO_0005041 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 3.19e-03 | 301 | 187 | 7 | DOID:684 (is_marker_for) | |
| Disease | Cardiomyopathy | 3.31e-03 | 47 | 187 | 3 | cv:C0878544 | |
| Disease | hypertension (biomarker_via_orthology) | 3.35e-03 | 227 | 187 | 6 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Adenocarcinoma Of Esophagus | 3.46e-03 | 14 | 187 | 2 | C0279628 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.73e-03 | 49 | 187 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 3.82e-03 | 100 | 187 | 4 | C0010606 | |
| Disease | Alzheimer disease | 3.94e-03 | 485 | 187 | 9 | MONDO_0004975 | |
| Disease | Hypogonadotropic hypogonadism | 3.97e-03 | 15 | 187 | 2 | C0271623 | |
| Disease | Primary hypogonadism | 3.97e-03 | 15 | 187 | 2 | C0948896 | |
| Disease | Hypogonadism, Isolated Hypogonadotropic | 3.97e-03 | 15 | 187 | 2 | C3489396 | |
| Disease | coronary artery disease | ITGA1 IGSF10 GMDS MRTFA HJV FNDC3B COL6A3 FAT4 SORBS2 DNAH10 DYNC2H1 IGF2BP1 THADA LOXL1 ATP2B1 TNXB | 4.01e-03 | 1194 | 187 | 16 | EFO_0001645 |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 4.03e-03 | 398 | 187 | 8 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | platelet measurement | 4.09e-03 | 315 | 187 | 7 | EFO_0005036 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 4.17e-03 | 51 | 187 | 3 | cv:CN043650 | |
| Disease | red blood cell density measurement | PIEZO1 ITGA1 ADGRV1 NUP205 PTPRF GMDS WASHC2C EP400 DNAH10 CAPZA2 SORBS1 JMJD1C MYO15A | 4.18e-03 | 880 | 187 | 13 | EFO_0007978 |
| Disease | Schizophrenia | MAGI1 ARHGAP32 PDZK1 PTPRA CEACAM21 KDR ALDH3B1 ALOX12 PON1 PTPN21 LEP ERVK-8 TNXB | 4.30e-03 | 883 | 187 | 13 | C0036341 |
| Disease | Hypogonadism | 4.52e-03 | 16 | 187 | 2 | C0020619 | |
| Disease | colorectal mucinous adenocarcinoma | 4.52e-03 | 16 | 187 | 2 | EFO_0009361 | |
| Disease | succinylcarnitine measurement | 4.52e-03 | 16 | 187 | 2 | EFO_0020020 | |
| Disease | complement factor H-related protein 3 measurement | 4.54e-03 | 169 | 187 | 5 | EFO_0600056 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 4.67e-03 | 243 | 187 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | immature platelet count | 4.69e-03 | 106 | 187 | 4 | EFO_0803544 | |
| Disease | Ischemic stroke | 4.77e-03 | 324 | 187 | 7 | HP_0002140 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 5.10e-03 | 17 | 187 | 2 | C1839839 | |
| Disease | response to radiation, Urinary retention | 5.10e-03 | 17 | 187 | 2 | GO_0009314, HP_0000016 | |
| Disease | Astrocytosis | 5.10e-03 | 17 | 187 | 2 | C3887640 | |
| Disease | Gliosis | 5.10e-03 | 17 | 187 | 2 | C0017639 | |
| Disease | Rheumatoid Arthritis | 5.13e-03 | 174 | 187 | 5 | C0003873 | |
| Disease | waist-hip ratio | CYP19A1 INSR NUP205 NOTUM FKBP4 IQUB FNDC3B IQCH DNAH10 DYNC2H1 DTX1 LINGO2 CEP192 JMJD1C THADA LOXL1 | 5.14e-03 | 1226 | 187 | 16 | EFO_0004343 |
| Disease | phenylalanine measurement | 5.16e-03 | 55 | 187 | 3 | EFO_0005001 | |
| Disease | Liver carcinoma | 5.24e-03 | 507 | 187 | 9 | C2239176 | |
| Disease | intraocular pressure measurement | 5.37e-03 | 509 | 187 | 9 | EFO_0004695 | |
| Disease | neutrophil percentage of leukocytes | CYP19A1 ETS1 ELMO1 MRTFA JMJD1C THADA CELA3A IL1RN ARHGAP45 TOP2A | 5.75e-03 | 610 | 187 | 10 | EFO_0007990 |
| Disease | adverse effect, response to xenobiotic stimulus | 6.28e-03 | 59 | 187 | 3 | EFO_0009658, GO_0009410 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QVKAVEYAVRGPIVL | 56 | Q8TD30 | |
| AAAEVPEVLQGLYQA | 406 | Q17RC7 | |
| PLRINGVKVYTENVD | 246 | A0FGR8 | |
| YEDVILQPGTQEALK | 1336 | Q96L91 | |
| YQKVAQEITIGQLIP | 216 | Q92556 | |
| KAVLAELPQQVVQYF | 521 | Q96FN4 | |
| IEVAGPNSYKEIIQN | 126 | P14060 | |
| NELIEINPQSEGKVY | 261 | Q07092 | |
| QFTPVKIEGYEDQVL | 61 | P52907 | |
| VEKILAEVLPQYVDQ | 146 | P43353 | |
| IPTIGFNVETVEYKN | 46 | P84085 | |
| KTVEPNQLIAAYVID | 71 | Q3KPI0 | |
| IAGKVERNIPEVYVA | 4286 | Q6V0I7 | |
| GATYKVDVVPIKNQV | 4826 | Q8WXG9 | |
| IDYDVELQELQIPGK | 91 | O95342 | |
| IPTIGFNVETVEYKN | 46 | P61204 | |
| ITRLQDQQVPYAVKG | 316 | Q15782 | |
| EITYENVQVPAVLGV | 36 | P21854 | |
| ENGEVLPLKIVTYAA | 2461 | Q9NYQ6 | |
| GNIPYEATEEQLKDI | 21 | P33240 | |
| ENLIKYGILVDPIQV | 106 | O75907 | |
| PVADITVGDIAQVKY | 206 | P20020 | |
| AVGDIVKVVNGQYLP | 171 | Q9NTI2 | |
| VKVVNGQYLPADVVL | 176 | Q9NTI2 | |
| IAIYEKAILAGAQPI | 481 | Q8WWK9 | |
| YEKVPVILVGNKVDL | 106 | P10114 | |
| LVYKIVIPAIANGSQ | 426 | Q8TBY0 | |
| IDQKVYQAEVDNLPV | 231 | Q6ZVN8 | |
| NYAIPEVKIKGNNLV | 311 | Q86VS3 | |
| TQKTYEVNEVGVLNP | 291 | Q8N442 | |
| QFVELQGEEIIAYKP | 786 | Q92621 | |
| AAQPGYLVTKVVAVD | 581 | Q9Y5F8 | |
| VNGVNVLDEPYEKVV | 426 | Q5T2W1 | |
| KAILGDYSQQPLVQV | 461 | O43747 | |
| VIDVLLGEQDQYVPN | 866 | P20585 | |
| TIQQGEIYKIPAAEN | 306 | Q5KSL6 | |
| ITDVKPGNYILQVVI | 681 | P58215 | |
| QRAEVVVQVPYLEAG | 991 | Q92619 | |
| NQKEPVGLSIDYVEN | 1731 | Q9NZR2 | |
| LDKEPIIVNGQETYD | 576 | Q96QZ7 | |
| TLPAGEQRKDVYVQL | 26 | P42166 | |
| LEAEGFQVTYLPVQK | 166 | Q9Y697 | |
| TQENIYIGKVNVPLI | 871 | Q68CZ1 | |
| IINEVKPTEIYNLGA | 96 | O60547 | |
| NYIVQKGLAVPELRD | 2111 | Q9UKN7 | |
| EEVVYNQLNGLAKPI | 71 | Q9HCQ5 | |
| VQVISYQGIEPKLNI | 96 | Q06546 | |
| PAGEAVLQYSVEVQV | 1701 | Q8NDA2 | |
| YNPERTITVKGAIEN | 321 | Q9NZI8 | |
| DVVNILVYVGIAKGN | 2341 | Q15652 | |
| YAVPGKSLEEQNEVI | 251 | Q9BVA6 | |
| VPLGEELAAIQKTYI | 291 | Q8IYD8 | |
| IDITDVQPGNYILKV | 521 | Q08397 | |
| ILQKEDVKPYQVNGV | 131 | P14921 | |
| IQYQVDKGPVDAVTG | 1481 | Q9ULL4 | |
| GIVKAVAAQDPVIYS | 2711 | Q9NYQ8 | |
| VSPYVNGEIQKAEIR | 211 | P80217 | |
| PGLQAEVTKAQEYLV | 331 | Q96B70 | |
| VQSRANGVKYPELVL | 186 | Q9Y5H3 | |
| VLVGIPLETGQKQYN | 126 | Q9BT78 | |
| AANIVQVKLGSPDYV | 166 | Q16877 | |
| QDQAYKAPVVVEGKV | 121 | O14511 | |
| YDIGVINAPQQVIIS | 26 | P11168 | |
| PKILEYSEEQLGNVV | 186 | Q96J66 | |
| INPVKVANLVKAYVD | 1611 | Q9P1Y6 | |
| DQPIYLAVKGVVFDV | 61 | Q9UMX5 | |
| LFYVQAVPIQKVQDD | 16 | P41159 | |
| IVPEVKDYAAIVEQN | 731 | Q9UL01 | |
| YVPRKNNGAVVEGEV | 581 | Q7L985 | |
| IVSYQVIGEDNVAVP | 211 | Q9Y2C4 | |
| TLPAGEQRKDVYVQL | 26 | P42167 | |
| DYLDVPSNIAKIIIG | 946 | P06213 | |
| LDGIPANVIRGEKQY | 281 | P18054 | |
| PDVGINGVQNYELIK | 166 | Q9BZA7 | |
| VGPEAALVDVNVYLI | 686 | Q9Y5H7 | |
| VQQAEVYGIQEVPEL | 31 | Q6ZWE6 | |
| NVVNISIPVKYEVGL | 936 | P56199 | |
| VNSPIVTENKYIEVG | 611 | A7KAX9 | |
| VLGQVDAQLVPYIID | 61 | Q86Y01 | |
| VEQLIPYVEEDGSKN | 111 | Q96HR3 | |
| PLDENEGIYVQDVKT | 381 | Q14764 | |
| VVNFLVPNAVYDIVK | 91 | O94905 | |
| NGIINQYRVKVLVPE | 466 | Q9UMZ3 | |
| VRVELVPTKENNTGY | 936 | Q16825 | |
| ENVPIGTLVYVFNAK | 1521 | Q6V1P9 | |
| VIPQAEKAGIIRYAI | 271 | Q13349 | |
| GVPIYIKNLDETIND | 301 | Q96DU9 | |
| AEQLEKLGYPAIQVR | 246 | Q6P988 | |
| AELLVSQGVVNQPEY | 541 | Q02218 | |
| LDRYVQEQIPGAKVV | 1271 | Q96QU1 | |
| QLQEVIYPETLKLEG | 151 | P87889 | |
| QLQEVIYPETLKLEG | 151 | Q9YNA8 | |
| QLQEVIYPETLKLEG | 151 | P62683 | |
| QLQEVIYPETLKLEG | 151 | P63145 | |
| QLQGVIYPETLKLEG | 151 | Q9HDB9 | |
| QLQEVIYPETLKLEG | 151 | Q7LDI9 | |
| QLQEVIYPETLKLEG | 151 | P63130 | |
| QLQEVIYPETLKLEG | 151 | P62685 | |
| QLQEVIYPETLKLEG | 151 | P63126 | |
| QLQEVIYPETLKLEG | 151 | P62684 | |
| IIIGPFYINTDNVKQ | 801 | Q9P2D7 | |
| KDNIGDVVIKAIQPY | 3001 | Q9P2D7 | |
| DVVIKAIQPYIDNEE | 3006 | Q9P2D7 | |
| AQGPRYVVQIGDKII | 3346 | Q8NCM8 | |
| LAKGPQEVAVYVQEL | 276 | Q15075 | |
| IPLAKEGNYAIVANV | 791 | Q96A65 | |
| VIAGVIGAQKPQYDI | 1006 | Q08462 | |
| ITVVEPLVEAYQENG | 566 | Q6WRI0 | |
| PQEYILKGVVNAALG | 316 | A0AVF1 | |
| ADQPIQIYEKIVSGR | 241 | P22612 | |
| ETNEGVLSVVKPLNY | 411 | Q14574 | |
| IPLDESAIVVKIQGY | 206 | P11511 | |
| ADNLNGVYILQPEVI | 696 | Q9H799 | |
| PLNAEVVQYAKEVVD | 46 | Q9UKA2 | |
| GEYNLAVKEGPEQVI | 86 | P09093 | |
| KGDPVNYILQVLVGR | 1081 | Q53EP0 | |
| LQKAIGAVPLIQGEY | 311 | P07339 | |
| ELIVQPELKYGDGIQ | 86 | P15924 | |
| LNVKPEGTRIAVAQY | 866 | P12111 | |
| QGIIYIIIDGDPFKQ | 2216 | Q8TDW7 | |
| IPTIGFNVETVEYKN | 46 | P84077 | |
| VENLRKYVGEQVPSE | 246 | Q8TD31 | |
| AGEFKEQLQALIPYV | 286 | Q6DD88 | |
| GQQVEVELLGKNYPA | 826 | Q9UI17 | |
| VELLGKNYPAVIIQE | 831 | Q9UI17 | |
| TGLDQYQQVPVEIVK | 231 | Q8NA54 | |
| GNIEVYLDIKVPEQG | 1676 | Q8TEP8 | |
| ETNEGILNVIKPLDY | 331 | Q8IXH8 | |
| RIYVGNASVAQDIPK | 36 | P51452 | |
| NIEEVYVGGKQVVPF | 436 | Q9Y2T3 | |
| VAGYLQGPNVNLEEK | 56 | P18510 | |
| GNIPYEATEEQLKDI | 21 | Q9H0L4 | |
| LVGQVLVKPYIDEVI | 246 | Q14746 | |
| AVVQLPKNGPIYDVV | 266 | Q9BY44 | |
| SVNVPIQDGIQDEKY | 226 | Q9BY41 | |
| YAKPNEGAIVEVALE | 161 | Q02790 | |
| QKAIDVPGQVQVYEL | 496 | O95817 | |
| AVEQVLEENGYAVLP | 2076 | Q8IVF4 | |
| LEENGYAVLPIQVDK | 2081 | Q8IVF4 | |
| VGAPVAYVQQIFVKS | 86 | Q12770 | |
| LVYVVTNQAKPGDRI | 431 | Q8NEC7 | |
| PVATQIQQEVIKAYG | 56 | Q99622 | |
| EKQGTQEGAAVPIYV | 396 | O95396 | |
| KGAFYLAVQAQVPIV | 186 | O15120 | |
| IIPVKRGEENTDYVN | 576 | P18433 | |
| AVPFKILYNGQSVEV | 1041 | P10586 | |
| QAKGAPISAYQIVVE | 621 | Q15262 | |
| LQYAVPIISQQGEVA | 806 | Q9H1H9 | |
| LQYAVPIINQKGEVA | 816 | Q9NQT8 | |
| YQNVPGIEKVDDVVK | 76 | P82914 | |
| NQYPDINVITGVLKD | 881 | Q5VT97 | |
| YLECLKPVLNGVDQV | 1026 | P26640 | |
| ELEKQLVALIPYGDQ | 71 | Q96A25 | |
| VEVTDNALVNVYPVG | 126 | Q16518 | |
| NIIPYVADGAKAAIL | 1226 | Q6YHU6 | |
| LQEEAIDRNYVPGKV | 146 | Q9UMY4 | |
| EIKAEPGSLLQEYIN | 461 | O75602 | |
| PEIVNFVQKIVDNGY | 246 | P49589 | |
| AASGAEPQVLVQYLV | 16 | Q6GMV3 | |
| LTEEPKVTQVYAENG | 311 | P27169 | |
| IGIFPANYVKVIIDI | 541 | Q5HYK7 | |
| ANYVKVIIDIPEGGN | 546 | Q5HYK7 | |
| IQLGVPLENKENAEY | 106 | O76064 | |
| LSAEEYQQKIIPVVV | 341 | Q96KG9 | |
| ANKNEIPQLVGEIYQ | 326 | Q9H3E2 | |
| ELKPGVQVIVYVTQL | 1096 | Q9UPU3 | |
| QNISEGLVVYPKVIE | 356 | P30566 | |
| VLAVAKKAEYQLEPG | 91 | Q14940 | |
| GNGINVLKIAPEYAI | 151 | Q8N5S1 | |
| YRGDVVPKEVNAAIA | 326 | A6NHL2 | |
| PGVIEYKGANIQLLD | 101 | P55039 | |
| PKVEVSIVEVYNNDI | 116 | Q9UIL4 | |
| KEAIIVGQVNYPKVA | 96 | Q969V6 | |
| ENVGKPTIIEITAYN | 121 | O43556 | |
| QGIFPVSYVEVVKKN | 986 | O94875 | |
| QLQEVIYPETLKLEG | 151 | P63128 | |
| EINPLVVTKDGVYVL | 201 | P53396 | |
| YEDLVANGVIVPAQE | 801 | P53396 | |
| QFTPVKIEGYEDQVL | 61 | P47755 | |
| IPTIGFNVETVEYKN | 46 | P18085 | |
| KPVYIQDLDEIGQLA | 456 | Q8N3C0 | |
| LYEEAIKNGATPIQE | 576 | Q8IYA6 | |
| INALEAYQKTGQEIP | 141 | Q96KP4 | |
| PYSDLVKEELNIIQG | 406 | Q9NRU3 | |
| VKGQQELLYVVPFVA | 1226 | A5YKK6 | |
| PKQLIQQVGNEAYVI | 1226 | Q96JI7 | |
| LEDLYSQKVIQAPGI | 1381 | A4UGR9 | |
| GPNVKAVATAVEQIY | 161 | P62380 | |
| QNGEPAEIKIIREAY | 6 | Q8N0X7 | |
| GYFVEAQPKIVLGQE | 141 | P02743 | |
| AVPEVAVYLKESVGN | 166 | Q15257 | |
| GEINPVKVSNLVRAY | 1256 | Q9H7N4 | |
| VEAKINQEREGIGYP | 141 | P63121 | |
| GYVNAQLEKEVPIFT | 31 | Q9P253 | |
| LTPVQVLEYGEAIAK | 861 | Q9BX66 | |
| VVQYKDKDGRLQVVP | 3386 | P22105 | |
| VEAKINQEREGIGYP | 141 | P63131 | |
| PGEEYIVNVVALKEQ | 476 | Q92752 | |
| YGNNVEKVPIDIIVN | 276 | Q9GZR1 | |
| EVDLIPKVQEAVNYG | 126 | Q9Y4E1 | |
| PKVQEAVNYGLQVLD | 131 | Q9Y4E1 | |
| LDVNIQIYPVDLGDK | 41 | P52434 | |
| KVIQGQTDPEYLLLG | 1126 | P11277 | |
| VNPIKLYEENKVIAG | 301 | Q9HCJ6 | |
| VEAKINQEREGIGYP | 141 | P10265 | |
| KGTIEELAPNQYVIS | 896 | P11388 | |
| ELAPNQYVISGEVAI | 901 | P11388 | |
| EVDLIPKVQEAVNYG | 126 | Q641Q2 | |
| PKVQEAVNYGLQVLD | 131 | Q641Q2 | |
| IKQELQYTQEGPADL | 216 | Q9UDV6 | |
| GIVIVLNPDVYTKNK | 66 | Q9NYW2 | |
| ANAQQDGKDYIVLPI | 1166 | P35968 | |
| VKQLQPNEEADYLGV | 2371 | Q92508 | |
| PLLQVGDYVFAKIVI | 1091 | Q502W6 | |
| PLYKILAQVVGDVDT | 376 | Q15029 | |
| VDQNLLKEYFPVQVV | 351 | P52888 | |
| LVVEEGLNQLPYKEC | 146 | Q96BW1 | |
| ALQGPILQKDYVQLE | 256 | Q6P9G9 | |
| QVPVNLEDVAVYLSG | 221 | O60304 | |
| RKPAEVLIVEGQQYA | 726 | Q9P1Q0 | |
| VPYEIQKGQALITFE | 96 | Q13287 |